|
|
40
|
|
|
A3941
|
|
|
SERETIDE MDI 50/25 INHR (GSK/COL) FLUTICASONE
|
|
|
FLUTICASONE|SALMETEROL
|
|
|
SERETIDE MDI
|
|
|
120 DOSES
|
|
|
C
|
|
|
48.20
|
|
|
48.20
|
|
|
50MCG|25MCG
|
|
|
INHALER
|
|
|
0
|
|
|
INHR
|
|
|
GSK
|
|
|
GLAXOSMITHKLINE
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
B
|
|
|
Anti-Asthmatic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
4892
|
|
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
|
ORAL INHALATION
|
|
|
0
|
|
|
RESPIRATORY TRACT AGENTS
|
|
|
|